Form 8.3
LONDON--( BUSINESS WIRE)--
Ap27
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
(a) Full name of discloser
Qube Research & Technologies Limited
(b) Owner or controller of interests and short positions disclosed, if different from 1(a)
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates
Use a separate form for each offeror/offeree
Avadel Pharmaceuticals plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)
(e) Date position held/dealing undertaken
For an opening position disclosure, state the latest practicable date prior to the disclosure
11/02/2026
(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state “N/A”
YES / NO / N/A
If YES, specify which: Please fill in manually
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Ap28
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
(Note 2)
Class of relevant security
(Note 3)
$0.01 ordinary shares
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled
3,288,219.00
3.37
(2) Cash-settled derivatives
(3) Stock-settled derivatives (including options) and agreements to purchase/ sell
Total
3,288,219.00
3.37
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant
Purchase/sale
Number of
Price per unit
security
securities
(Note 5)
USD 0.01 ordinary shares
Purchase
1170576
21.64
USD 0.01 ordinary shares
Purchase
700
21.645
USD 0.01 ordinary shares
Purchase
40091
21.65
USD 0.01 ordinary shares
Purchase
600
21.653
USD 0.01 ordinary shares
Purchase
29192
21.655
USD 0.01 ordinary shares
Purchase
100
21.658
USD 0.01 ordinary shares
Purchase
89750
21.66
USD 0.01 ordinary shares
Purchase
704
21.662
USD 0.01 ordinary shares
Purchase
78
21.662
USD 0.01 ordinary shares
Purchase
267
21.662
USD 0.01 ordinary shares
Purchase
341
21.662
USD 0.01 ordinary shares
Purchase
1300
21.663
USD 0.01 ordinary shares
Purchase
37
21.663
USD 0.01 ordinary shares
Purchase
1138
21.663
USD 0.01 ordinary shares
Purchase
972
21.664
USD 0.01 ordinary shares
Purchase
264
21.664
USD 0.01 ordinary shares
Purchase
602
21.664
USD 0.01 ordinary shares
Purchase
496
21.664
USD 0.01 ordinary shares
Purchase
78
21.665
USD 0.01 ordinary shares
Purchase
47962
21.665
USD 0.01 ordinary shares
Purchase
187
21.667
USD 0.01 ordinary shares
Purchase
285
21.667
USD 0.01 ordinary shares
Purchase
380
21.667
USD 0.01 ordinary shares
Purchase
194
21.667
USD 0.01 ordinary shares
Purchase
50111
21.67
USD 0.01 ordinary shares
Purchase
78
21.671
USD 0.01 ordinary shares
Purchase
82
21.672
USD 0.01 ordinary shares
Purchase
202
21.672
USD 0.01 ordinary shares
Purchase
17
21.672
USD 0.01 ordinary shares
Purchase
665
21.672
USD 0.01 ordinary shares
Purchase
2000
21.673
USD 0.01 ordinary shares
Purchase
127
21.673
USD 0.01 ordinary shares
Purchase
142
21.674
USD 0.01 ordinary shares
Purchase
55
21.674
USD 0.01 ordinary shares
Purchase
2239
21.675
USD 0.01 ordinary shares
Purchase
61627
21.675
USD 0.01 ordinary shares
Purchase
141
21.675
USD 0.01 ordinary shares
Purchase
116
21.676
USD 0.01 ordinary shares
Purchase
171
21.676
USD 0.01 ordinary shares
Purchase
231
21.677
USD 0.01 ordinary shares
Purchase
1108
21.677
USD 0.01 ordinary shares
Purchase
136
21.677
USD 0.01 ordinary shares
Purchase
124
21.677
USD 0.01 ordinary shares
Purchase
84
21.677
USD 0.01 ordinary shares
Purchase
391
21.677
USD 0.01 ordinary shares
Purchase
73
21.677
USD 0.01 ordinary shares
Purchase
43
21.678
USD 0.01 ordinary shares
Purchase
1847
21.679
USD 0.01 ordinary shares
Purchase
99
21.679
USD 0.01 ordinary shares
Purchase
83
21.68
USD 0.01 ordinary shares
Purchase
77922
21.68
USD 0.01 ordinary shares
Purchase
1246
21.68
USD 0.01 ordinary shares
Purchase
256
21.68
USD 0.01 ordinary shares
Purchase
292
21.68
USD 0.01 ordinary shares
Purchase
3006
21.681
USD 0.01 ordinary shares
Purchase
1410
21.681
USD 0.01 ordinary shares
Purchase
1496
21.681
USD 0.01 ordinary shares
Purchase
861
21.681
USD 0.01 ordinary shares
Purchase
35
21.681
USD 0.01 ordinary shares
Purchase
273
21.681
USD 0.01 ordinary shares
Purchase
190
21.681
USD 0.01 ordinary shares
Purchase
252
21.682
USD 0.01 ordinary shares
Purchase
388
21.682
USD 0.01 ordinary shares
Purchase
3230
21.682
USD 0.01 ordinary shares
Purchase
1821
21.682
USD 0.01 ordinary shares
Purchase
2013
21.682
USD 0.01 ordinary shares
Purchase
3363
21.682
USD 0.01 ordinary shares
Purchase
1362
21.682
USD 0.01 ordinary shares
Purchase
512
21.682
USD 0.01 ordinary shares
Purchase
1349
21.682
USD 0.01 ordinary shares
Purchase
670
21.682
USD 0.01 ordinary shares
Purchase
1566
21.683
USD 0.01 ordinary shares
Purchase
327
21.683
USD 0.01 ordinary shares
Purchase
1273
21.683
USD 0.01 ordinary shares
Purchase
61
21.683
USD 0.01 ordinary shares
Purchase
197
21.683
USD 0.01 ordinary shares
Purchase
431
21.683
USD 0.01 ordinary shares
Purchase
164
21.684
USD 0.01 ordinary shares
Purchase
94
21.684
USD 0.01 ordinary shares
Purchase
654
21.684
USD 0.01 ordinary shares
Purchase
123
21.684
USD 0.01 ordinary shares
Purchase
40
21.684
USD 0.01 ordinary shares
Purchase
150
21.685
USD 0.01 ordinary shares
Purchase
387
21.685
USD 0.01 ordinary shares
Purchase
240
21.685
USD 0.01 ordinary shares
Purchase
84337
21.685
USD 0.01 ordinary shares
Purchase
1441
21.685
USD 0.01 ordinary shares
Purchase
2917
21.685
USD 0.01 ordinary shares
Purchase
354
21.686
USD 0.01 ordinary shares
Purchase
177
21.686
USD 0.01 ordinary shares
Purchase
63695
21.69
USD 0.01 ordinary shares
Purchase
125
21.69
USD 0.01 ordinary shares
Purchase
43
21.691
USD 0.01 ordinary shares
Purchase
43
21.691
USD 0.01 ordinary shares
Purchase
72
21.692
USD 0.01 ordinary shares
Purchase
89
21.692
USD 0.01 ordinary shares
Purchase
500
21.693
USD 0.01 ordinary shares
Purchase
88
21.693
USD 0.01 ordinary shares
Purchase
129
21.693
USD 0.01 ordinary shares
Purchase
43
21.693
USD 0.01 ordinary shares
Purchase
196
21.693
USD 0.01 ordinary shares
Purchase
32
21.694
USD 0.01 ordinary shares
Purchase
66
21.694
USD 0.01 ordinary shares
Purchase
188
21.694
USD 0.01 ordinary shares
Purchase
91
21.694
USD 0.01 ordinary shares
Purchase
129
21.694
USD 0.01 ordinary shares
Purchase
245
21.695
USD 0.01 ordinary shares
Purchase
70
21.695
USD 0.01 ordinary shares
Purchase
313
21.695
USD 0.01 ordinary shares
Purchase
55733
21.695
USD 0.01 ordinary shares
Purchase
116
21.695
USD 0.01 ordinary shares
Purchase
89
21.695
USD 0.01 ordinary shares
Purchase
197
21.696
USD 0.01 ordinary shares
Purchase
225
21.696
USD 0.01 ordinary shares
Purchase
85
21.696
USD 0.01 ordinary shares
Purchase
116
21.696
USD 0.01 ordinary shares
Purchase
384
21.696
USD 0.01 ordinary shares
Purchase
181
21.696
USD 0.01 ordinary shares
Purchase
48
21.697
USD 0.01 ordinary shares
Purchase
206
21.698
USD 0.01 ordinary shares
Purchase
190
21.698
USD 0.01 ordinary shares
Purchase
114
21.698
USD 0.01 ordinary shares
Purchase
151
21.698
USD 0.01 ordinary shares
Purchase
178
21.698
USD 0.01 ordinary shares
Purchase
284
21.698
USD 0.01 ordinary shares
Purchase
96
21.698
USD 0.01 ordinary shares
Purchase
261
21.699
USD 0.01 ordinary shares
Purchase
111
21.699
USD 0.01 ordinary shares
Purchase
91
21.699
USD 0.01 ordinary shares
Purchase
262
21.699
USD 0.01 ordinary shares
Purchase
98
21.7
USD 0.01 ordinary shares
Purchase
91756
21.7
USD 0.01 ordinary shares
Purchase
159
21.7
USD 0.01 ordinary shares
Purchase
175
21.7
USD 0.01 ordinary shares
Purchase
284
21.7
USD 0.01 ordinary shares
Purchase
93
21.7
USD 0.01 ordinary shares
Purchase
109
21.701
USD 0.01 ordinary shares
Purchase
169
21.701
USD 0.01 ordinary shares
Purchase
212
21.701
USD 0.01 ordinary shares
Purchase
100
21.701
USD 0.01 ordinary shares
Purchase
170
21.701
USD 0.01 ordinary shares
Purchase
217
21.702
USD 0.01 ordinary shares
Purchase
101
21.702
USD 0.01 ordinary shares
Purchase
351
21.702
USD 0.01 ordinary shares
Purchase
94
21.702
USD 0.01 ordinary shares
Purchase
155
21.702
USD 0.01 ordinary shares
Purchase
588
21.702
USD 0.01 ordinary shares
Purchase
603
21.702
USD 0.01 ordinary shares
Purchase
383
21.703
USD 0.01 ordinary shares
Purchase
643
21.703
USD 0.01 ordinary shares
Purchase
774
21.703
USD 0.01 ordinary shares
Purchase
270
21.703
USD 0.01 ordinary shares
Purchase
435
21.703
USD 0.01 ordinary shares
Purchase
298
21.703
USD 0.01 ordinary shares
Purchase
394
21.703
USD 0.01 ordinary shares
Purchase
308
21.703
USD 0.01 ordinary shares
Purchase
202
21.703
USD 0.01 ordinary shares
Purchase
438
21.704
USD 0.01 ordinary shares
Purchase
354
21.704
USD 0.01 ordinary shares
Purchase
57
21.704
USD 0.01 ordinary shares
Purchase
1095
21.704
USD 0.01 ordinary shares
Purchase
2184
21.704
USD 0.01 ordinary shares
Purchase
20112
21.705
USD 0.01 ordinary shares
Purchase
2800
21.709
USD 0.01 ordinary shares
Purchase
31969
21.71
USD 0.01 ordinary shares
Purchase
2300
21.715
USD 0.01 ordinary shares
Purchase
6553
21.72
USD 0.01 ordinary shares
Purchase
400
21.723
USD 0.01 ordinary shares
Purchase
2320
21.725
USD 0.01 ordinary shares
Purchase
4561
21.73
USD 0.01 ordinary shares
Purchase
7000
21.74
USD 0.01 ordinary shares
Purchase
5634
21.743
USD 0.01 ordinary shares
Purchase
2515
21.744
USD 0.01 ordinary shares
Purchase
264
21.744
USD 0.01 ordinary shares
Purchase
3108
21.745
USD 0.01 ordinary shares
Purchase
334
21.745
USD 0.01 ordinary shares
Purchase
324
21.745
USD 0.01 ordinary shares
Purchase
9600
21.749
USD 0.01 ordinary shares
Purchase
27532
21.75
USD 0.01 ordinary shares
Purchase
289
21.75
USD 0.01 ordinary shares
Purchase
259
21.75
USD 0.01 ordinary shares
Purchase
290
21.75
USD 0.01 ordinary shares
Purchase
363
21.751
USD 0.01 ordinary shares
Purchase
800
21.753
USD 0.01 ordinary shares
Purchase
72291
21.755
USD 0.01 ordinary shares
Purchase
866
21.76
USD 0.01 ordinary shares
Sale
24
21.64
Ap29
(b) Cash-settled derivative transactions
Class of
relevant
security
Product
description
e.g. CFD
Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position
Number of
reference
securities
(Note 6)
Price
per unit
(Note 5)
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of
relevant
security
Product
description e.g. call
option
Writing, purchasing, selling, varying
etc.
Number
of
securities
to which
option
relates
(Note 6)
Exercise
price per
unit
Type
e.g.
American,
European
etc.
Expiry
date
Option
money
paid/
received per unit
(ii) Exercise
Class of
relevant
security
Product
description
e.g. call
option
Exercising/
exercised
against
Number of
securities
Exercise
price per
unit
(Note 5)
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Class of
relevant
security
Nature of dealing
e.g. subscription,
conversion, exercise
Details
Price per unit (if
applicable)
(Note 5)
Ap30
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
(c) Attachments
Is a Supplemental Form 8 attached?
NO
Date of disclosure
11/02/2026
Contact name
Janice Falcao
Telephone number
00442070722969
Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
Ap31
NOTES ON FORM 8.3
1. See the definition of “connected fund manager” in Rule 2.2 of Part A of the Rules.
2. See the definition of “interest in a relevant security” in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.
3. See the definition of “relevant securities” in Rule 2.1 of Part A of the Rules.
4. See the definition of “dealing” in Rule 2.1 of Part A of the Rules.
5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.
6. See Rule 2.5(d) of Part A of the Rules.
7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.